Page 10 - Indian Healthcare

Health insurance that is 'Cashless Everywhere': Here's how it works

This initiative, spearheaded by the General Insurance Council, aims to simplify claims processing, mitigate fraud, and bolster overall industry trust

Half of health, pharma cos to integrate GenAI solutions under 1 yr: Report

The report said that 28 per cent of healthcare and pharma companies had already implemented their first GenAI solutions

Active Covid cases hit one-month low, shows health ministry data

Doctors say JN.1 not the only reason for Covid spike last month

ICMR invites suggestions for revising national essential diagnostics list

It is unclear whether the finalisation of the NEDL will lead to price capping of diagnostic tests in line with drugs

Hospitals, blood banks can only charge processing fees for blood: Govt

Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging. In a communication to all states and UT drugs controllers cum licensing authorities, the Drugs Controller Genral of India (DCGI) stated that the decision was taken in view of the opinion that "blood is not for sale". Referring to the 62nd meeting of the Drugs Consultative Committee held on September 26, 2023, the DCGI in the letter on December 26 said, "It was recommended with respect of agenda No. 18 of ATR point 3, for overcharging of blood, it was opined that blood is not for sale, it is only for supply and only processing cost may be charged by the blood centre." The revised guidelines stipulate that only processing fees can be charged for blood or blood components which ranges between Rs 250 to 1,550 for blood or blood components. The DCGI has asked states and UT drug controllers to direct all blood

As Covid-19 cases rise in India; should you keep pharma stocks on radar?

Barring Dr Lal Pathlabs, the other four healthcare related stocks listed below seem to be trapped in a range for now, charts suggest.

Focus shifts to healthcare delivery in 2023 as Covid stress eases

After three long years of Covid-induced turbulence, 2023 saw a semblance of normalcy in the health sector, allowing the government to turn its attention to other important commitments such as the elimination of sickle cell disease and the launch of Ayushman Bhav to ensure optimum delivery of health schemes. However, by the end of the year, the Covid scare resurfaced as the number of daily cases began to rise due to the emergence of new sub-variant JN.1 and cold weather conditions, prompting the health ministry to step up surveillance. The year began with concerns over the XBB.1.16 variant of the coronavirus leading to some rise in cases, but it eventually petered out, allowing the health ministry officials to focus on other priority areas. A major initiative this year has been the launch of the National Sickle Cell Anaemia Elimination Mission by Prime Minister Narendra Modi in July. The mission is aimed at elimination of the disease in India, particularly among the country's tribal

Health insurance: Govt to discuss 24-hr hospitalisation rule with Irdai

President of NCDRC, Justice Amreshwar Prasap Sahi, said that some district forums have innovated and ordered insurance cos to clear claims even when hospitalisation was less than 24 hrs

Centre may set up regulator for healthcare to expand insurance coverage

A regulator for the healthcare sector is expected to bring in standardisation and lower the costs

Govt improving citizens' health with holistic approach, campaigns: Shah

The Centre has taken up the mission to improve the health of citizens with a holistic approach by increasing the budget for it and launching various schemes and campaigns during the last one decade, Union Minister Amit Shah said here on Saturday. Addressing the 6th Advancements in Endourology Conference, Shah also thanked doctors and paramedical staff for working with dedication in the fight against COVID-19. "The Union as well as state governments and doctors across the country are working together with a holistic approach to improve the health of the people through the implementation of schemes prepared minutely during the last 10 years," he said. "The biggest work was to increase the health budget from Rs 33,000 crore to Rs 1.33 lakh crore. The government worked to improve the health infrastructure and increase human resources required for modern medical science," he added. Campaigns such as Swachh Bharat Yojana launched for prevention of diseases as well as initiatives to take

PharmEasy bags Rs 1.3K cr from Pai; Rs 3.5K cr rights issue oversubscribed

Besides Pai's commitment, PharmEasy raised the remaining Rs 2,200 crore from existing shareholders

Max Healthcare Institute acquires Starlit Medical Centre for Rs 940 crore

Within its current network, it has 3,533 beds, and following this acquisition, the total bed count would approximately touch around 4,083 beds

Advent International may sell majority stake in Bharat Serums & Vaccines

Global PE major in initial talks with Indian as well as foreign investors

Margin gains likely to further boost Aster DM Healthcare stock price

The company had been keen to sell the stake in the GCC business for some time now given a hypercompetitive environment, lower growth (a third of the India business) and lower margins

Experts warn of Covid spike in Kerala as vaccine-induced immunity wanes

Kerala now has 194 active cases, accounting for 61 per cent of the active cases in India

India's workforce faces rising medical inflation, reveals report

The report also revealed nearly 59 per cent skip their annual health checkups, while 90 per cent neglect regular doctor consultations to monitor their health

Rs 3 lakh is the median sum insured offered by India's employers: survey

Fifty-six per cent of companies offer maternity benefits, while less than one per cent of companies offer holistic cover for people with disabilities and 60% of companies offer new age insurance

Hospitals get post-Covid growth injection from foreign medical tourism

Robust growth in H1FY24 signals rebound in medical tourism, fuels bigger expectations

Oriental Insurance hopes to turn profitable by end of FY24: R R Singh

The public sector non-life insurer narrowed its losses to Rs 47.12 crore in the first half of the financial year 2024 from Rs 3,586.93 crore recorded in the same period a year ago

Biocon biologics receives marketing approval by MHRA for YESAFILI in UK

This approval follows the green light granted by the European Commission (EC) for marketing authorisation in the European Union (EU) back in September